NewslettersMammary Cell NewsCMTM6 Overexpression Confers Trastuzumab Resistance in HER2-Positive Breast CancerBy Noshin Noorjahan - January 19, 20230132Scientists uncovered a role of CKLF-like MARVEL transmembrane domain-containing 6 (CMTM6) in trastuzumab-resistant HER2+ breast cancer. CMTM6 expression was upregulated in trastuzumab-resistant HER2+ breast cancer cell.[Molecular Cancer]Full Article